Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review
Chronic lymphocytic leukemia (CLL) incidence increases with age reaching 37.9/100,000 in patients over 85 years. Although there is no standardized geriatric tool specifically validated for CLL, a correct framing of the fitness status is of critical importance to individualize treatment strategies. B...
Guardado en:
Autores principales: | Alberto Fresa, Francesco Autore, Eugenio Galli, Annamaria Tomasso, Luca Stirparo, Idanna Innocenti, Luca Laurenti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bb44eb70a48d474689f67be0d09c9237 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review
por: Francesco Autore, et al.
Publicado: (2021) -
Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia
por: Seiter K, et al.
Publicado: (2015) -
An unusual presentation of chronic lymphocytic leukemia
por: Dinesh Atwal, et al.
Publicado: (2017) -
An unusual presentation of chronic lymphocytic leukemia
por: Dinesh Atwal, et al.
Publicado: (2017) -
Chronic lymphocytic leukemia in general practice
por: Đurović Ljiljana P.
Publicado: (2021)